Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

TBK1 and IKKε Act Redundantly to Mediate STING-Induced NF-κB Responses in Myeloid Cells
Katherine R. Balka, Cynthia Louis, Tahnee L. Saunders, et al.
Cell Reports (2020) Vol. 31, Iss. 1, pp. 107492-107492
Open Access | Times Cited: 331

Showing 1-25 of 331 citing articles:

The cGAS–STING pathway as a therapeutic target in inflammatory diseases
Alexiane Decout, Jason D. Katz, Shankar Venkatraman, et al.
Nature reviews. Immunology (2021) Vol. 21, Iss. 9, pp. 548-569
Open Access | Times Cited: 1369
TDP-43 Triggers Mitochondrial DNA Release via mPTP to Activate cGAS/STING in ALS
Chien‐Hsiung Yu, Sophia Davidson, Cassandra R. Harapas, et al.
Cell (2020) Vol. 183, Iss. 3, pp. 636-649.e18
Open Access | Times Cited: 694
Autophagy in inflammation, infection, and immunometabolism
Vojo Deretić
Immunity (2021) Vol. 54, Iss. 3, pp. 437-453
Open Access | Times Cited: 576
TBK1 recruitment to STING activates both IRF3 and NF-κB that mediate immune defense against tumors and viral infections
Seoyun Yum, Minghao Li, Yan Fang, et al.
Proceedings of the National Academy of Sciences (2021) Vol. 118, Iss. 14
Open Access | Times Cited: 371
Chemical and Biomolecular Strategies for STING Pathway Activation in Cancer Immunotherapy
Kyle M. Garland, Taylor L. Sheehy, John T. Wilson
Chemical Reviews (2022) Vol. 122, Iss. 6, pp. 5977-6039
Open Access | Times Cited: 211
The cGAS–STING signaling in cardiovascular and metabolic diseases: Future novel target option for pharmacotherapy
Patrick Kwabena Oduro, Xianxian Zheng, Jinna Wei, et al.
Acta Pharmaceutica Sinica B (2021) Vol. 12, Iss. 1, pp. 50-75
Open Access | Times Cited: 187
STING promotes senescence, apoptosis, and extracellular matrix degradation in osteoarthritis via the NF-κB signaling pathway
Qiang Guo, Ximiao Chen, Jiaoxiang Chen, et al.
Cell Death and Disease (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 165
Molecular mechanisms of mitochondrial DNA release and activation of the cGAS-STING pathway
Jeonghan Kim, Ho‐Shik Kim, Jay H. Chung
Experimental & Molecular Medicine (2023) Vol. 55, Iss. 3, pp. 510-519
Open Access | Times Cited: 154
STING mediates neurodegeneration and neuroinflammation in nigrostriatal α-synucleinopathy
Jared T. Hinkle, Jaimin Patel, Nikhil Panicker, et al.
Proceedings of the National Academy of Sciences (2022) Vol. 119, Iss. 15
Open Access | Times Cited: 125
Genomic instability, inflammatory signaling and response to cancer immunotherapy
Mengting Chen, Renske Linstra, Marcel A.T.M. van Vugt
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2021) Vol. 1877, Iss. 1, pp. 188661-188661
Open Access | Times Cited: 120
Clathrin-associated AP-1 controls termination of STING signalling
Ying Liu, Pengbiao Xu, Sophie Rivara, et al.
Nature (2022) Vol. 610, Iss. 7933, pp. 761-767
Open Access | Times Cited: 93
Multifaceted functions of STING in human health and disease: from molecular mechanism to targeted strategy
Zili Zhang, Haifeng Zhou, Xiaohu Ouyang, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 93
NF-κB activation enhances STING signaling by altering microtubule-mediated STING trafficking
Lulu Zhang, Xubiao Wei, Zhimeng Wang, et al.
Cell Reports (2023) Vol. 42, Iss. 3, pp. 112185-112185
Open Access | Times Cited: 87
Exploiting innate immunity for cancer immunotherapy
Ming Yi, Tianye Li, Mengke Niu, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 84
Biochemistry, Cell Biology, and Pathophysiology of the Innate Immune cGAS–cGAMP–STING Pathway
Christopher Ritchie, Jacqueline A. Carozza, Lingyin Li
Annual Review of Biochemistry (2022) Vol. 91, Iss. 1, pp. 599-628
Open Access | Times Cited: 82
The volume-regulated anion channel LRRC8C suppresses T cell function by regulating cyclic dinucleotide transport and STING–p53 signaling
Axel R. Concepcion, Larry E. Wagner, Jingjie Zhu, et al.
Nature Immunology (2022) Vol. 23, Iss. 2, pp. 287-302
Open Access | Times Cited: 81
Targeting STING to promote antitumor immunity
Emily N. Chin, Ariana Sulpizio, Luke L. Lairson
Trends in Cell Biology (2022) Vol. 33, Iss. 3, pp. 189-203
Closed Access | Times Cited: 74
ESCRT-dependent STING degradation inhibits steady-state and cGAMP-induced signalling
Matteo Gentili, Bingxu Liu, Malvina Papanastasiou, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 69
How the Innate Immune DNA Sensing cGAS-STING Pathway Is Involved in Apoptosis
Wanglong Zheng, Anjing Liu, Nengwen Xia, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 3029-3029
Open Access | Times Cited: 46
Signaling pathways in macrophages: molecular mechanisms and therapeutic targets
Ming Li, Mengjie Wang, Yuanjia Wen, et al.
MedComm (2023) Vol. 4, Iss. 5
Open Access | Times Cited: 46
Context-dependent activation of STING-interferon signaling by CD11b agonists enhances anti-tumor immunity
Xiuting Liu, Graham D. Hogg, Chong Zuo, et al.
Cancer Cell (2023) Vol. 41, Iss. 6, pp. 1073-1090.e12
Open Access | Times Cited: 45
The balance of STING signaling orchestrates immunity in cancer
Klara Rasmussen Bollerup Lanng, Emil Leth Lauridsen, Martin R. Jakobsen
Nature Immunology (2024) Vol. 25, Iss. 7, pp. 1144-1157
Closed Access | Times Cited: 42
Inhibition of NF-κB signaling unveils novel strategies to overcome drug resistance in cancers
Yuanfang Li, Baiwei Zhao, Juzheng Peng, et al.
Drug Resistance Updates (2024) Vol. 73, pp. 101042-101042
Open Access | Times Cited: 37
Nanomaterial-encapsulated STING agonists for immune modulation in cancer therapy
Xi Chen, Zhijie Xu, Tongfei Li, et al.
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 24
A STING–CASM–GABARAP pathway activates LRRK2 at lysosomes
Amanda Bentley‐DeSousa, Agnes Roczniak-Ferguson, Shawn M. Ferguson
The Journal of Cell Biology (2025) Vol. 224, Iss. 2
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top